Skip to content

First-in-human safety study of pancreatic islet transplantation without immune suppression in adult subjects with type 1 diabetes

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-507988-19-00
Acronym
UP421-ET1D
Enrollment
2
Registered
2023-11-16
Start date
2024-03-08
Completion date
Unknown
Last updated
2024-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes type I

Interventions

None listed

Sponsors

Uppsala University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026